# R61/33 - VR Study Phase 4

> **NCT07169760** · PHASE4 · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 252 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **BEHAVIORAL:** Meta Quest 3 VR Headset with noise cancelling headphones

## Key facts

- **NCT ID:** NCT07169760
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2030-09
- **Final completion:** 2030-12
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169760, "R61/33 - VR Study Phase 4". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07169760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*